These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7872303)

  • 1. Please, not another marker of cancer risk in Barrett's esophagus!
    Fennerty MB; Sampliner RE
    Am J Gastroenterol; 1995 Mar; 90(3):511-2. PubMed ID: 7872303
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk estimation in Barrett's esophagus: biomolecular marker and histopathologic classification].
    Walch A; Schmitt-Gräff A; Stein H; Werner M
    Zentralbl Chir; 2002 Dec; 127(12):1073-7. PubMed ID: 12529823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen in the assessment of Barrett's mucosa.
    Gillen P; McDermott M; Grehan D; Hourihane DO; Hennessy TP
    Br J Surg; 1994 Dec; 81(12):1766-8. PubMed ID: 7827934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett's esophagus.
    Byrd D; McKinley MJ; Floch MH; Nair S
    Gastroenterologist; 1994 Jun; 2(2):160-5. PubMed ID: 8055240
    [No Abstract]   [Full Text] [Related]  

  • 5. High-grade dysplasia in Barrett's esophagus: an evolving clinical dilemma.
    Sampliner RE
    Am J Gastroenterol; 1993 Nov; 88(11):1811-2. PubMed ID: 8237924
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of proliferating cell nuclear antigen expression in dysplastic intestinal type Barrett's esophagus. Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
    Lapertosa G; Baracchini P; Fulcheri E
    Pathologica; 1994 Apr; 86(2):174-9. PubMed ID: 7936762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
    Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Barrett's esophagus. Metaplasia-dysplasia-cancer: inexorable change?].
    Tamayo de la Cuesta JL
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():40-4. PubMed ID: 15146792
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the clinical significance of stromal angiogenesis in Barrett's esophagus?
    Moriyama N; Amano Y; Mishima Y; Okita K; Takahashi Y; Yuki T; Ishimura N; Ishihara S; Kinoshita Y
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S210-5. PubMed ID: 19120900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation.
    Byrne JP; Armstrong GR; Attwood SE
    Am J Gastroenterol; 1998 Oct; 93(10):1810-5. PubMed ID: 9772036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus and Barrett's-related dysplasia.
    Goldblum JR
    Mod Pathol; 2003 Apr; 16(4):316-24. PubMed ID: 12692197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we worry about the length of Barrett's esophagus?
    Shaheen NJ
    Gastrointest Endosc; 2005 Nov; 62(5):682-5. PubMed ID: 16246679
    [No Abstract]   [Full Text] [Related]  

  • 17. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D; Schmitt C; Wong JB
    Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma.
    Helm J; Enkemann SA; Coppola D; Barthel JS; Kelley ST; Yeatman TJ
    Clin Cancer Res; 2005 Apr; 11(7):2478-85. PubMed ID: 15814623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
    Asthana N; Mandich D; Ligato S
    Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
    Vieth M; Schubert B; Lang-Schwarz K; Stolte M
    Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.